Patent ID: 7951801

Claim:
A compound of formula III-A-aa: or a pharmaceutically acceptable salt thereof wherein, Q is —CH 2 — or CH(R 9 ); G is morpholinyl optionally substituted by 1-2 R 10 ; R 1 is hydrogen, halo,C 1-2 alkyl, amino, or (C 1-2 alkyl) 1-2 amino R 2 is hydrogen, halo, C 1-2 aliphatic, C 1-2 alkoxy, or C 1-2 haloalkyl; R 3 is hydrogen, halo, C 1-2 aliphatic, C 1-2 alkoxy, or C 1-2 haloalkyl; each R 6b is independently methyl; each R 7 is independently selected from hydrogen or C 1-4 aliphatic, or two R 7 on the same nitrogen atom are taken together with the nitrogen to form a 5-6 membered heteroaryl or heterocyclyl ring; each R 8 is independently C 1-4 aliphatic; each R 9 is independently selected from a C 1-3 aliphatic; each R 10 is independently selected from R 11 , T-R 11 , or V-T-R 11 ; each R 11 is independently selected from C 1-6 aliphatic, halo, —OR 7 , —CN, —SR 8 , —S(O) 2 R 8 , —C(O)R 7 , —CO 2 R 7 , —N(R 7 ) 2 , —C(O)N(R 7 ) 2 , —N(R 7 )C(O)R 7 , —N(R 7 )CO 2 R 7 , or —N(R 7 )C(O)N(R 7 ) 2 ; T is a straight or branched C 1-4 alkylene chain; and V is —O—, —N(R 7 )—, —S—, —S(O) 2 —, —C(O)—, or —CO 2 —.